Summit Therapeutics Inc. logo

Summit Therapeutics Inc.

SMMT | NASDAQ
Chart Builder DCF Calculator
$17.02
+$0.12 (+0.71%)
Sep 22, 2026, 1:48 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
167.18M 83.79M 56.52M 284.18M 53.22M 48.78M
Short-Term Investments
362.31M 245.71M 90.86M n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
5.35M 2.04M 4.18M 470.37K 126.02K n/a
Receivables
n/a 445.09K 671.07K 4.98M 12.72M 7.48M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
5.09M 8.67M 143.24K 244.95M 890.27K 1.12M
Total Current Assets
534.58M 338.61M 150.13M 535.35M 72.14M 64.4M
Property-Plant & Equipment
16.09M 5.91M 4.8M 4.14M 2.58M 939.44K
Goodwill & Intangibles
1.49M 1.49M 1.5M 1.47M 9.2M 9.95M
Total Long-Term Assets
22.92M 9.44M 10.48M 6.08M 11.91M 10.89M
Total Assets
557.5M 348.05M 160.6M 541.43M 84.04M 75.29M
Account Payables
15.06M 3.7M 2.11M 289.39K 3.24M 4.51M
Deferred Revenue
n/a n/a n/a n/a 5.88M 6.15M
Short-Term Debt
n/a n/a n/a 16.12M n/a n/a
Other Current Liabilities
12.77M 11.01M 4.86M 5.14M 3.72M 1.26M
Total Current Liabilities
54.17M 33.35M 16.15M 31.61M 18.99M 14.61M
Long-Term Debt
n/a n/a 79.14M 403.15M n/a n/a
Other Long-Term Liabilities
1.36M 1.3M 1.24M 1.16M 2.06M 1.84M
Total Long-Term Liabilities
14.35M 4.06M 82.98M 406.56M 3.31M 2.32M
Total Liabilities
68.52M 37.41M 99.12M 438.18M 22.3M 16.93M
Total Debt
15.5M 5.77M 83.96M 422.89M 2.06M 341.55K
Book Value
488.98M 310.64M 61.48M 103.25M 61.74M 58.36M
Book Value Per Share
0.65 0.43 0.10 0.53 0.67 0.84
Common Stock
5.75M 5.89M 5.55M 1.72M 726.45K 606.7K
Retained Earnings
-1.7B -970.55M -786.02M -308.41M -222.05M -154.94M
Comprehensive Income
-1.89M -1.83M -1.94M -1.54M -1.63M -2.79M
Shareholders Equity
488.98M 310.64M 61.48M 103.25M 61.74M 58.36M
Total Investments
362.31M 245.71M 90.86M n/a n/a n/a

© 2026 bestshares.com. All rights reserved.